Abstract
Background High-dimensional clinical data are becoming more accessible in biobank-scale datasets. However, accurately phenotyping high-dimensional clinical data remains a major impediment to genetic discovery.
Methods We introduce a general deep learning framework, RE presentation learning for Genetic discovery on Low-dimensional Embeddings (REGLE), for discovering associations between genetic variants and high-dimensional clinical data. REGLE uses convolutional variational autoencoders to compute a non-linear, low-dimensional, disentangled embedding of the data and can also incorporate expert clinical metrics. We demonstrate the utility of REGLE by application to spirograms, which measure lung function. We generate two types of synthetic representations of pulmonary functions we call spirogram encodings (SPINCs) and residual spirogram encodings (RSPINCs).
Findings Genome-wide association studies on (R)SPINCs identify more genome-wide significant loci than existing methods while replicating most known lung function loci. Furthermore, (R)SPINCs are associated with overall survival and, under the latent causal variable model, they exhibit significantly high genetic causality proportion with asthma, chronic obstructive pulmonary disease (COPD), and inflammatory diseases. Finally, we construct a set of polygenic risk scores (PRS) that are generally predictive of pulmonary traits and diseases. We demonstrate superior performance predicting asthma and COPD, in multiple ancestries and across four biobanks, compared to PRSs constructed using expert-defined pulmonary function measurements.
Interpretation REGLE is a method for generating low-dimensional, disentangled representations of high-dimensional clinical data that does not require labels, and improves upon expert-defined phenotypes for genetic discovery and disease prediction. It can flexibly incorporate expert-defined or clinical features and provides a framework to create accurate disease-specific PRS in datasets which have minimal expert phenotyping. (R)SPINCs are quantifying clinically relevant features that are not currently captured in a standardized or automated way.
Funding Google LLC.
Competing Interest Statement
T.Y., J.C., B.B., Z.R.M., J.B., H.Y., A.C., C.Y.M., and F.H. are current or former employees of Google or Verily Life Sciences and own Alphabet stock as part of the standard compensation package.
Funding Statement
T.Y., J.C., B.B., Z.R.M., J.B., H.Y., A.C., C.Y.M., and F.H. are current or former employees of Google or Verily Life Sciences and received salary, bonus, and stock awards as part of the standard compensation package. B.D.H. was supported by NIH R01 HL162813, U01 HL089856, R01 HL155749, and a Research Grant from the Alpha-1 Foundation. M.H.C. was supported by NHLBI R01HL153248, R01HL149861, and R01HL147148.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Advarra IRB (Columbia, MD) waived ethical approval for this work involving de-identified medical imagery and metadata under 45 CFR 46. Work related to genomics data were additionally reviewed by the respective data sources: UK Biobank, COPDGene, eMERGE III, EPIC Norfolk, and Indiana Biobank. This research has been conducted using the UK Biobank Resource under Application Number 65275.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Datasets used in this study (UK Biobank, COPDGene, eMERGE III, EPIC Norfolk, and Indiana Biobank) are available to qualified researchers via applying access to each dataset maintainers. All results derived from UK Biobank by this study will be returned to UK Biobank and will be made available by UK Biobank maintainers. Open-source code used for this study is available on GitHub at https://github.com/Google-Health/genomics-research under "spirogram-encodings" directory.
